Stawasz, A., Huang, L., Kirby, P., & Bloom, D. (2020). Health Technology Assessment for Vaccines Against Rare, Severe Infections: Properly Accounting for Serogroup B Meningococcal Vaccination's Full Social and Economic Benefits. Front Public Health.
Stile di citazione ChicagoStawasz, Andrew, Liping Huang, Paige Kirby, e David Bloom. "Health Technology Assessment for Vaccines Against Rare, Severe Infections: Properly Accounting for Serogroup B Meningococcal Vaccination's Full Social and Economic Benefits." Front Public Health 2020.
Citazione MLAStawasz, Andrew, Liping Huang, Paige Kirby, e David Bloom. "Health Technology Assessment for Vaccines Against Rare, Severe Infections: Properly Accounting for Serogroup B Meningococcal Vaccination's Full Social and Economic Benefits." Front Public Health 2020.